Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 31, 2015
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adultsAlicia L Danforth, Christopher M Struble, Berra Yazar-Klosinski, et al.Neuropharmacology|August 16, 2022
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicinesSean J Belouin, Lynnette A Averill, Jack E Henningfield, et al.Archives of General Psychiatry|September 8, 2010
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancerCharles S Grob, Alicia L Danforth, Gurpreet S Chopra, et al.Psychopharmacology|September 10, 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot studyAlicia L Danforth, Charles S Grob, Christopher Struble, et al.Journal of Psychoactive Drugs|March 27, 2019
Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic AdultsAlicia L DanforthThe Journal of Pain|June 1, 2022
If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of PsychedelicsRobert H Dworkin, Brian T Anderson, Nick Andrews, et al.The Lancet. Psychiatry|April 13, 2016
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMAMichael C Mithoefer, Charles S Grob, Timothy D BrewertonJournal of the American Academy of Child and Adolescent Psychiatry|May 11, 2024
Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With CautionJessica K Jeffrey, Marc J Weintraub, Charles S GrobThe American Journal of Psychiatry|January 29, 2005
Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalitiesLinda Chang, Thomas Ernst, Oliver Speck, et al.Pageof 5